Does FOLLITROPIN Cause Ovarian hyperstimulation syndrome? 718 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 718 reports of Ovarian hyperstimulation syndrome have been filed in association with FOLLITROPIN (Gonal-f RFF Redi-ject). This represents 25.7% of all adverse event reports for FOLLITROPIN.
718
Reports of Ovarian hyperstimulation syndrome with FOLLITROPIN
25.7%
of all FOLLITROPIN reports
4
Deaths
570
Hospitalizations
How Dangerous Is Ovarian hyperstimulation syndrome From FOLLITROPIN?
Of the 718 reports, 4 (0.6%) resulted in death, 570 (79.4%) required hospitalization, and 31 (4.3%) were considered life-threatening.
Is Ovarian hyperstimulation syndrome Listed in the Official Label?
Yes, Ovarian hyperstimulation syndrome is listed as a known adverse reaction in the official FDA drug label for FOLLITROPIN.
What Other Side Effects Does FOLLITROPIN Cause?
Ascites (213)
No adverse event (213)
Abdominal distension (154)
Headache (151)
Nausea (129)
Abdominal pain (115)
Product quality issue (111)
Abortion spontaneous (102)
Dyspnoea (101)
Incorrect dose administered (86)
What Other Drugs Cause Ovarian hyperstimulation syndrome?
CHORIOGONADOTROPIN ALFA (1,016)
GANIRELIX (672)
TRIPTORELIN (356)
PROGESTERONE (293)
MENOTROPINS (238)
LUTROPIN ALFA (194)
GONADOTROPHIN, CHORIONIC (173)
FOLLITROPIN BETA (163)
FOLLITROPIN ALFA (138)
LETROZOLE (130)
Which FOLLITROPIN Alternatives Have Lower Ovarian hyperstimulation syndrome Risk?
FOLLITROPIN vs FOLLITROPIN ALFA
FOLLITROPIN vs FOLLITROPIN BETA
FOLLITROPIN vs FOLLITROPIN\LUTEINIZING HORMONE
FOLLITROPIN vs FOLLITROPIN\LUTROPIN ALFA
FOLLITROPIN vs FONDAPARINUX